Comparison of Biolimus A9–Eluting (Nobori) and Everolimus-Eluting (Promus Element) Stents in Patients With De Novo Native Long Coronary Artery LesionsJong‐Young Lee, Seung‐Jung Park, Seong‐Wook Park et al.|Circulation Cardiovascular Interventions|2014Cited by 34
Three-Month Dual Antiplatelet Therapy After Implantation of Zotarolimus-Eluting Stents - The DATE (Duration of Dual Antiplatelet Therapy After Implantation of Endeavor Stent) Registry -Joo‐Yong Hahn, The DATE Registry Investigators, Young Bin Song et al.|Circulation Journal|2010Cited by 26
Effectiveness and Safety of Biolimus A9™-Eluting stEnt in Patients with AcUTe Coronary sYndrome; A Multicenter, Observational Study (BEAUTY Study)Keun Ho Park, Jin‐Yong Hwang, Young Joon Hong et al.|Yonsei Medical Journal|2017Cited by 2
Efficacy and Safety of 3 Versus 6 Months of Dual-Antiplatelet Therapy in Patients Implanted With Coroflex ISAR Stents: A Prospective, Multicenter, Randomized Clinical TrialUram Jin, Myeong‐Ho Yoon, Kyoung‐Woo Seo et al.|The Journal of invasive cardiology/The journal of invasive cardiology|2022Cited by 1